News
April 9, 2024
Clustering Trajectories to Study Diabetic Kidney Disease
Distefano V, Mannone M, Poli I, Mayer G. In: Villani, M., Cagnoni, S., Serra, R.…
April 4, 2024
Exploiting the Potential of Bayesian Networks in Deriving New Insight into Diabetic Kidney Disease (DKD)
Slanzi D, Silvestri C, Poli, I, Mayer G. In: Villani, M., Cagnoni, S., Serra, R.…
February 19, 2024
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease
Tarunveer S. Ahluwalia, Teemu K.E. Rönkkö, Mie K. Eickhoff, Viktor Rotbain Curovic, Justyna Siwy, Susanne…
February 12, 2024
The DC-ren partner mosaiques diagnostics provides highly innovative Clinical Proteomics services for academic institutions and pharmaceutical companies
The second periodic report is completed and DC-ren met all major project milestones.
December 31, 2023
DC-ren project status
The second periodic report is completed and DC-ren met all major project milestones.
December 29, 2023
Context and overall objectives of the project.
Diabetic Kidney Disease (DKD) is a serious clinical condition, and the incidence increases in parallel…
December 22, 2023
Big data and precision medicine
December 18, 2023
Why do we need precision medicine? What about inter-, and most of intraindividual heterogeneity in DKD? A video with Arno Lukas from EMTEC
Why do we need precision medicine? What about inter-, and most of intraindividual heterogeneity in…
December 18, 2023
Why is diabetic kidney disease an important problem in Europe? A video with Sara Denicolo from The Medical University of Innsbruck
Why is diabetic kidney disease an important problem in Europe? What is the current approach…
December 14, 2023
DC-ren associated studies
The concept of precision medicine as proposed by DC-ren is also of great interest to…
November 29, 2023
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.
Ahluwalia TS, Rönkkö TKE, Eickhoff MK, Curovic VR, Siwy J, Eder S, Denicolò S, Mayer…
November 20, 2023
DC-ren GENERAL ASSEMBLY 2023
Members of the DC-ren consortium, convened for the meeting at the AC Hotel in Innsbruck,…
November 17, 2023
Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.
Møller AL, Thöni S, Keller F, Sharifli S, Rasmussen DGK, Genovese F, Karsdal MA, Mayer…
November 1, 2023
Candidate composite biomarker to inform drug treatments for diabetic kidney disease.
Jones RD, Abebe S, Distefano V, Mayer G, Poli I, Silvestri C, Slanzi D.Front Med…
September 14, 2023
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.
Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C,…
December 31, 2022
Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.
Denicolò S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G, Ju W, Perco…
February 3, 2022
Clonal hematopoiesis of indeterminate potential and diabetic kidney disease: a nested case-control study.
Denicolò S, Vogi V, Keller F, Thöni S, Eder S, Heerspink HJL, Rosivall L, Wiecek…
September 9, 2021
DC-ren associated study initiated.
First periodic report completed. DC-ren met major project milestones.